Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
20,250,000
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
2,145,805
-
Shares change
-
+107,342
-
Total reported value, excl. options
-
$8,111,390
-
Value change
-
+$183,530
-
Put/Call ratio
-
0%
-
Number of buys
-
8
-
Number of sells
-
8
-
Price
-
$3.78
Institutional Holders of enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) as of Q2 2022
As of 30 Jun 2022 enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) had 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,145,805 shares of stock of the company.
Largest 10 holders included PERCEPTIVE ADVISORS LLC, ACT CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, KINGDON CAPITAL MANAGEMENT, L.L.C., UBS OCONNOR LLC, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA ADVISERS, LP, BlackRock Inc., MORGAN STANLEY, and ARTHUR M. COHEN & ASSOCIATES, LLC.
This table shows 26 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.